CALA Calithera Biosciences Inc

Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

As of 10/18/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/02/2014
Outstanding shares:  74,114,399
Average volume:  529,805
Market cap:   $154,899,094
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    13089P101
ISIN:        US13089P1012
Valuation   (See tab for details)
PE ratio:   -10.56
PB ratio:   1.82
PS ratio:   51.63
Return on equity:   -96.38%
Net income %:   -2,666.87%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy